OEM Customized Rivaroxaban CAS No. 366789-02-8 Pharmaceutical Raw Material

Our products are broadly regarded and reliable by end users and can meet up with constantly transforming financial and social requires of OEM Customized Rivaroxaban CAS No. 366789-02-8 Pharmaceutical Raw Material, We never stop improving our technique and high quality to maintain up with the enhancement trend of this industry and fulfill your pleasure effectively. For anyone who is fascinated within our solutions, you should get in touch with us freely.
Our products are broadly regarded and reliable by end users and can meet up with constantly transforming financial and social requires of China Chemical and Pharmaceutical Raw Material, We have the best solutions and qualified sales and technical team.With the development of our company, we are able to deliver customers best products, good technical support, perfect after-sales service.

Used in adult patients with elective hip or knee replacement surgery to prevent venous thrombosis (VTE).

It is used to prevent or reduce the formation of thrombosis, deep vein thrombosis (DVT) and pulmonary embolism (PE) after hip or knee replacement surgery.

The recommended dose is oral rivaroxaban 10mg, once a day. Rivaroxaban 10mg can be taken with food or alone. Rivaroxaban 15mg or 20mg tablets should be taken with food.

standard: usp40
Assay: 99-102%

Exterior: White powder
Package : 25kg/drum

Take 4-(4-aminophenyl) morpholin-3-one (SM-1), (S)-N-glycidyl phthalimide (SM-2), 5-chlorothiophene-2- Formyl chloride (SM-3) is the starting material. After condensation, cyclization, aminolysis and acylation, the crude rivaroxaban is obtained, and the finished rivaroxaban is refined.
Preparation: This product is a red film-coated tablet.

Accessories:
Tablet core: microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, hypromellose, sodium lauryl sulfate, magnesium stearate
Coating: polyethylene glycol, hypromellose, titanium dioxide, iron oxide red

Rivaroxaban is a highly selective, oral drug that directly inhibits factor Xa. Through highly selective and competitive inhibition of free and bound factor Xa and prothrombin activity, prolong the activated partial thromboplastin time plate (PT) and prothrombin time (aPTT) in a dose-dependent manner, which can interrupt the coagulation waterfall The endogenous and exogenous pathways inhibit the production of thrombin and thrombosis. Rivaroxaban does not inhibit thrombin (activating factor Ⅱ), nor has it proven to have an effect on platelets
The essential difference between rivaroxaban and fondaparinux/heparin is that it does not require the participation of antithrombin III and can directly antagonize free and bound factor Xa; while heparin requires antithrombin III to function, and It has no effect on factor Xa in the prothrombin complex.

Our products are broadly regarded and reliable by end users and can meet up with constantly transforming financial and social requires of OEM Customized Rivaroxaban CAS No. 366789-02-8 Pharmaceutical Raw Material, We never stop improving our technique and high quality to maintain up with the enhancement trend of this industry and fulfill your pleasure effectively. For anyone who is fascinated within our solutions, you should get in touch with us freely.
OEM Customized China Chemical and Pharmaceutical Raw Material, We have the best solutions and qualified sales and technical team.With the development of our company, we are able to deliver customers best products, good technical support, perfect after-sales service.